DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | (FY)Sep 30, 2017 | (FY)Sep 30, 2016 | (FY)Sep 30, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 967.08%29.5M | 105.18%2.76M | -654.04%-53.34M | 114.22%9.63M | -79.64%4.49M | 599.85%22.08M | -366.85%-4.42M | -105.66%-946K | 73.78%16.72M | -69.12%9.62M |
Other non cashItems | -67.70%351.44K | -53.88%1.09M | -4.30%2.36M | 12.21%2.47M | 21.59%2.2M | 28.55%1.81M | 61.83%1.41M | 49.72%868.63K | 79.89%580.17K | 459.71%322.52K |
Change in working capital | -108.97%-85.98K | 93.38%958.95K | 17.84%495.9K | 237.50%420.84K | -165.87%-306.06K | 146.19%464.62K | 186.61%188.72K | -56.56%65.85K | 182.18%151.58K | 239.87%53.72K |
-Change in receivables | -125.47%-204.27K | 467.54%802.03K | -75.41%141.32K | 135.76%574.6K | -60.39%243.72K | 4,834.79%615.29K | 86.06%-13K | 33.43%-93.23K | -430.67%-140.05K | 208.25%42.35K |
-Change in other current assets | 91.85%-5.78K | ---70.9K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20K |
-Change in other current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -67.17%15.9M | 20,566.41%48.41M | -100.76%-236.55K | 135.50%31.21M | -41.35%13.25M | 185.72%22.59M | -11.98%7.91M | 1,606.57%8.98M | -103.73%-596.27K | 0.02%16M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | 80.91%-8M | -495.33%-41.91M | 144.68%10.6M | -489.44%-23.73M | 71.85%-4.03M | ---14.3M | --0 | -71.30%2.2M | 205.80%7.67M | ---7.25M |
Net commonstock issuance | --0 | --0 | ---1.5M | ---- | --0 | --0 | ---- | ---- | ---- | 88.68%-287.32K |
Cash dividends paid | -26.43%-8.09M | 15.37%-6.4M | 17.98%-7.56M | -5.14%-9.22M | 2.91%-8.77M | -2.20%-9.03M | 8.67%-8.84M | 13.56%-9.68M | 0.42%-11.2M | -3.30%-11.24M |
Net other financing activities | 130.14%198.04K | 12.80%-657.1K | -147.67%-753.58K | 637.81%1.58M | -139.67%-293.93K | 194.03%740.93K | 130.58%251.99K | -200.00%-824.02K | --824.02K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 67.54%-15.9M | -6,325.09%-48.96M | 102.51%786.55K | -139.62%-31.37M | 42.06%-13.09M | -163.09%-22.59M | -3.43%-8.59M | -206.61%-8.3M | 85.58%-2.71M | -39.88%-18.78M |
Net cash flow | ||||||||||
Beginning cash position | --0 | --550K | --0 | --160.92K | --0 | ---- | --680.18K | --0 | -45.68%3.3M | 73.22%6.08M |
Current changes in cash | --0 | -200.00%-550K | 441.79%550K | -200.00%-160.92K | --160.92K | --0 | -200.00%-680.18K | 120.58%680.18K | -18.91%-3.3M | -208.07%-2.78M |
End cash position | --0 | --0 | --550K | --0 | --160.92K | --0 | --0 | --680.18K | --0 | -45.68%3.3M |
Free cash flow | -67.17%15.9M | 20,566.41%48.41M | -100.76%-236.55K | 135.50%31.21M | -41.35%13.25M | 185.72%22.59M | -11.98%7.91M | 1,606.57%8.98M | -103.73%-596.27K | 0.02%16M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |